Cargando…
4-Phenylbutyric acid enhances the mineralization of osteogenesis imperfecta iPSC-derived osteoblasts
Osteogenesis imperfecta (OI) is a heritable brittle bone disease mainly caused by mutations in the two type I collagen genes. Collagen synthesis is a complex process including trimer formation, glycosylation, secretion, extracellular matrix (ECM) formation, and mineralization. Using OI patient-deriv...
Autores principales: | Takeyari, Shinji, Kubota, Takuo, Ohata, Yasuhisa, Fujiwara, Makoto, Kitaoka, Taichi, Taga, Yuki, Mizuno, Kazunori, Ozono, Keiichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7948972/ https://www.ncbi.nlm.nih.gov/pubmed/33154166 http://dx.doi.org/10.1074/jbc.RA120.014709 |
Ejemplares similares
-
A novel COL1A1 deletion/insertion pathogenic
variant in a patient with osteogenesis imperfecta
por: Yamada, Chieko, et al.
Publicado: (2022) -
Association of trabecular bone score and bone mineral apparent density with the severity of bone fragility in children and adolescents with osteogenesis imperfecta: A cross-sectional study
por: Ohata, Yasuhisa, et al.
Publicado: (2023) -
Neonatal cholestasis can be the first symptom of McCune–Albright syndrome: A case report
por: Satomura, Yoshinori, et al.
Publicado: (2021) -
A family with brachydactyly mental retardation syndrome with a missense
variant in HDAC4
por: Takeyari, Shinji, et al.
Publicado: (2023) -
Metreleptin treatment for congenital generalized lipodystrophy type 4 (CGL4):
a case report
por: Takeyari, Shinji, et al.
Publicado: (2019)